InsiderTrades

Form 4 for PTCT PTC THERAPEUTICS, INC.

Accepted 2023-04-19 00:00:00 ET · period of report 2023-04-17 · accession 0001415889-23-006696 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-04-19 2023-04-17 PTCT SOUTHWELL DAVID P Dir S - Sale+OE $51.03 -11.4K 10.5K -52% -$583.2K
D 2023-04-19 2023-04-17 PTCT SOUTHWELL DAVID P Dir M - OptEx $18.01 +11.4K 21.9K +109% +$205.8K
D 2023-04-19 2023-04-17 PTCT SOUTHWELL DAVID P Dir M - OptEx $18.01 -11.4K 0 -100% -$205.8K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-04-17 S D 6,241 $50.69 15,688 D — — (F2) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $50.00 to $50.97 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
2 Common Common Stock 2023-04-17 M A 11,429 $18.01 21,929 D — —
3 Common Common Stock 2023-04-17 S D 5,188 $51.43 10,500 D — — (F3) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $51.01 to $51.835 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
4 Derivative Stock Option (Right to Buy) 2023-04-17 M D 11,429 $18.01 0 D $18.01 · — to 2028-01-02 11,429 Common Stock (F4) Currently exercisable.